assessment and device selection for vascular access
TRANSCRIPT
![Page 1: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/1.jpg)
![Page 2: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/2.jpg)
ALL CARE
DELIVERED NEEDS
TO BE EVIDENCE
BASED.
![Page 3: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/3.jpg)
![Page 4: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/4.jpg)
• Research
1 STEP
• Publication
2 STEP• Change in
practice
3 STEP
• SAFEST/BEST CARE POSSIBLE
GOAL
![Page 5: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/5.jpg)
![Page 6: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/6.jpg)
SO MANY INFORMATIONS AND SO LITTLE TIME!!
![Page 7: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/7.jpg)
RCN
INS
AVA
WEB SEARCH :ATHENS,
![Page 8: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/8.jpg)
PRACTICE
EDUCATION
ORGANIZATION/ STRUCTURE
![Page 9: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/9.jpg)
Assessment and Device Selection
Client Education
Documentation
![Page 10: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/10.jpg)
All clients requiring vascular access,
regardless of the duration of therapy.
RCN recommends the use of structured
approach and the development of a
vascular access care plan prior to the
initiation of therapy .
![Page 11: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/11.jpg)
Prescribed therapy
Duration of therapy
Physical assessment
Client health history
Supporting system/resources
Device availability
Client preferences
![Page 12: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/12.jpg)
Prescribed therapy
PH and Osmolarity
Frequency of blood sampling
Type of therapy
![Page 13: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/13.jpg)
ACID
NEUTRAL
ALCALINE
![Page 14: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/14.jpg)
The concentration of particles dissolved
in each solution .
In human plasma, the concentration of
dissolved paricles is about 290x10(3)
![Page 15: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/15.jpg)
![Page 16: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/16.jpg)
![Page 17: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/17.jpg)
![Page 18: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/18.jpg)
![Page 19: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/19.jpg)
![Page 20: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/20.jpg)
![Page 21: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/21.jpg)
A PH outside the range of 5-9 and/or
osmolarity greater than 500 Mosm/l
should be administered with a suitable
central venous device
![Page 22: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/22.jpg)
Maki(1991) :27-70 % of patient receiving
peripheral infusion therapy develop
phlebitis
The incidence of phlebitis rises
progressively with increasing length of
cannulation.
![Page 23: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/23.jpg)
30%
39-49%
70-88%DAY 2
DAY 3
DAY 4
![Page 24: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/24.jpg)
Mercer Ward ( oncology/haematology
and respiratory)
30 beds
December 2008 :12 patients with length
of stays between 7-15 days
11 patients on some forms of IV therapy
![Page 25: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/25.jpg)
![Page 26: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/26.jpg)
![Page 27: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/27.jpg)
![Page 28: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/28.jpg)
![Page 29: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/29.jpg)
![Page 30: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/30.jpg)
![Page 31: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/31.jpg)
![Page 32: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/32.jpg)
Vascular assessment and device
selection: RNAO , 2007
RCN” Guidelines for Intravenous
therapy”,2005
L.Doherty “ care and management of
central line catheters”,2006
![Page 33: ASSESSMENT AND DEVICE SELECTION FOR VASCULAR ACCESS](https://reader030.vdocument.in/reader030/viewer/2022020307/55990d1e1a28abba5b8b4804/html5/thumbnails/33.jpg)